Your browser doesn't support javascript.
loading
Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib.
Joensuu, Heikki; Eriksson, Mikael; Hall, Kirsten Sundby; Hartmann, Jörg T; Pink, Daniel; Schütte, Jochen; Ramadori, Giuliano; Hohenberger, Peter; Duyster, Justus; Al-Batran, Salah-Eddin; Schlemmer, Marcus; Bauer, Sebastian; Wardelmann, Eva; Sarlomo-Rikala, Maarit; Nilsson, Bengt; Sihto, Harri; Ballman, Karla V; Leinonen, Mika; DeMatteo, Ronald P; Reichardt, Peter.
Affiliation
  • Joensuu H; Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland.
Cancer ; 120(15): 2325-33, 2014 Aug 01.
Article in En | MEDLINE | ID: mdl-24737415
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Piperazines / Pyrimidines / Benzamides / Gastrointestinal Stromal Tumors / Antineoplastic Agents Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Cancer Year: 2014 Type: Article Affiliation country: Finland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Piperazines / Pyrimidines / Benzamides / Gastrointestinal Stromal Tumors / Antineoplastic Agents Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Cancer Year: 2014 Type: Article Affiliation country: Finland